Wyeth
Wyeth LLC is an American pharmaceutical and healthcare enterprise operating as a major subsidiary of Pfizer Inc, historically renowned as a leading global developer and manufacturer of prescription pharmaceutical drugs, vaccines, and consumer healthcare products. The company discovers, develops, and manufactures innovative therapeutic medicines, biological products, and nutritional formulations for global healthcare markets. Its core business operations encompass biopharmaceutical research, clinical drug development, pharmaceutical manufacturing, and global healthcare wholesale distribution. Revenue is derived directly from the global wholesale sale of pharmaceutical products and vaccines to medical distributors and healthcare providers. Wyeth holds an established historical position in pharmaceutical manufacturing and vaccine development. The company is headquartered in Madison, New Jersey, United States, operating as a specialized pharmaceutical enterprise.
3 of the funds FundTelligence covers report a position in Wyeth.
- Legal name
- Wyeth LLC
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 3
Funds holding Wyeth
- Nordea BetaPlus Enhanced US Corporate Bond — Nordea Funds · 0.46 % (full portfolio disclosed, September 2026)
- KLP Obligasjon Global — KLP · 0.07 % (partially disclosed portfolio, June 2026)
- DNB Global Credit — DNB · 0.04 % (full portfolio disclosed, September 2026)